1-40784268-C-T

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004700.4(KCNQ4):​c.175C>T​(p.Pro59Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,358,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P59L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

KCNQ4
NM_004700.4 missense

Scores

2
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0500
Variant links:
Genes affected
KCNQ4 (HGNC:6298): (potassium voltage-gated channel subfamily Q member 4) The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The current generated by this channel is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1570042).
BS2
High AC in GnomAdExome4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ4NM_004700.4 linkc.175C>T p.Pro59Ser missense_variant Exon 1 of 14 ENST00000347132.10 NP_004691.2 P56696-1B3KQH8
KCNQ4NM_172163.3 linkc.175C>T p.Pro59Ser missense_variant Exon 1 of 13 NP_751895.1 P56696-2B3KQH8
KCNQ4XM_047434057.1 linkc.175C>T p.Pro59Ser missense_variant Exon 1 of 13 XP_047290013.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ4ENST00000347132.10 linkc.175C>T p.Pro59Ser missense_variant Exon 1 of 14 1 NM_004700.4 ENSP00000262916.6 P56696-1
KCNQ4ENST00000509682.6 linkc.175C>T p.Pro59Ser missense_variant Exon 1 of 13 5 ENSP00000423756.2 P56696-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000511
AC:
6
AN:
117328
Hom.:
0
AF XY:
0.0000454
AC XY:
3
AN XY:
66086
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000299
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000103
AC:
14
AN:
1358762
Hom.:
0
Cov.:
31
AF XY:
0.0000149
AC XY:
10
AN XY:
671516
show subpopulations
Gnomad4 AFR exome
AF:
0.0000357
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000131
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.38e-7
Gnomad4 OTH exome
AF:
0.0000357
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000389
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Aug 10, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.175C>T (p.P59S) alteration is located in exon 1 (coding exon 1) of the KCNQ4 gene. This alteration results from a C to T substitution at nucleotide position 175, causing the proline (P) at amino acid position 59 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T;T;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.42
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.54
.;T;T
M_CAP
Pathogenic
0.97
D
MetaRNN
Benign
0.16
T;T;T
MetaSVM
Uncertain
0.71
D
MutationAssessor
Benign
0.76
N;N;N
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.16
.;N;N
REVEL
Uncertain
0.34
Sift
Benign
1.0
.;T;T
Sift4G
Benign
0.46
.;T;T
Polyphen
0.34
B;B;P
Vest4
0.090, 0.11
MutPred
0.21
Gain of phosphorylation at P59 (P = 0.0078);Gain of phosphorylation at P59 (P = 0.0078);Gain of phosphorylation at P59 (P = 0.0078);
MVP
0.76
MPC
2.3
ClinPred
0.12
T
GERP RS
1.7
Varity_R
0.059
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs772056095; hg19: chr1-41249940; API